Raremark gets £3m to enable precision medicine in rare disease

Oct 24, 2018 · uktech.news

Screen shot 2018 10 23 at 14.42.08 898x505

HealthTech company Raremark has raised £3m from investors. The round was led by AlbionVC and Ananda Ventures, with participation from Oltre Venture and from existing major investor the Cass Entrepreneurship Fund.

Julie Walters, CEO and founder of Raremark, commented on the news: "Healthcare is becoming increasingly personalized, and precision medicine is enabling the right treatments to be delivered to the right patients. However, accessing credible and structured, real-w0rld patient data remains one of the most acute challenges facing drug development in rare disease."

Lennart Hergel, partner at Ananda Ventures, explained Raremark’s approach: "Raremark has built a technology platform using content algorithms to boost engagement and advanced data analytics to understand the mechanisms, symptoms and heterogeneity of rare diseases. The resulting high-quality insights will enable companies to develop more effective treatments that are tailored to patients’ profiles."

Read Complete Article

RT @UKBAngels: As the 8th @MayorofLondon #TechInvest comes to a close we want to thank our incredible community partners for all their supp…

London’s greatest strength is that we are all welcome here and always will be. #LondonisOpen. Share if you agree. https://t.co/i8TTQuW71r

"The #FutureofWork is coming, in some cases it's already here." The 2019 Future of Work Summit was one of the highl… https://t.co/7QGtZmsUPR

Oracle patches another actively-exploited WebLogic zero-day https://t.co/Ov51p1fWuN

A key tip from James Newell @clearsalesmsg : "Sell the destination, not the journey. Show the beach, not the plane… https://t.co/ZSzDKR490H

More in London